Extracellular DNA traps in inflammation, injury and healing

C Daniel, M Leppkes, LE Muñoz, G Schley… - Nature Reviews …, 2019 - nature.com
Following strong activation signals, several types of immune cells reportedly release
chromatin and granular proteins into the extracellular space, forming DNA traps. This …

Complement and platelets: prothrombotic cell activation requires membrane attack complex–induced release of danger signals

M Mannes, V Pechtl, S Hafner, A Dopler… - Blood …, 2023 - ashpublications.org
Complement activation in the diseases paroxysmal nocturnal hemoglobinuria (PNH) and
atypical hemolytic uremic syndrome (aHUS) results in cytolysis and fatal thrombotic events …

Inhibition of immune complex complement activation and neutrophil extracellular trap formation by peptide inhibitor of complement C1

PS Hair, AI Enos, NK Krishna, KM Cunnion - Frontiers in immunology, 2018 - frontiersin.org
Two major aspects of systemic lupus erythematosus (SLE) pathogenesis that have yet to be
targeted therapeutically are immune complex-initiated complement activation and neutrophil …

The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy

NK Krishna, KM Cunnion, GA Parker - Frontiers in Immunology, 2022 - frontiersin.org
The EPICC peptides are a family of peptides that have been developed from the sequence
of the capsid protein of human astrovirus type 1 and previously shown to inhibit the classical …

Inhibition of myeloperoxidase activity in cystic fibrosis sputum by peptide inhibitor of complement C1 (PIC1)

PS Hair, LA Sass, NK Krishna, KM Cunnion - PLoS One, 2017 - journals.plos.org
Myeloperoxidase is the major peroxidase enzyme in neutrophil granules and implicated in
contributing to inflammatory lung damage in cystic fibrosis. Free myeloperoxidase is present …

Peptide inhibitor of complement C1 inhibits the peroxidase activity of hemoglobin and myoglobin

PS Hair, KM Cunnion… - International Journal of …, 2017 - Wiley Online Library
Hemoglobin is the natural carrier of oxygen in red blood cells (RBCs). While intracellular
hemoglobin provides life‐sustaining oxygen transport, extracellular free hemoglobin …

Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)

M Gregory Rivera, PS Hair, KM Cunnion, NK Krishna - PLoS One, 2018 - journals.plos.org
Reactive oxygen species (ROS) are natural byproducts of oxidative respiration that are toxic
to organs and tissues. To mitigate ROS damage, organisms have evolved a variety of …

Humanization of a mouse anti-human complement C6 monoclonal antibody as a potential therapeutic for certain complement-mediated diseases

L Zhang, K Armour, JY Chen, A Mylona, M Yang… - Molecular …, 2024 - Elsevier
The assembly of tissue-damaging membrane attack complexes (MACs; C5b–9) is a major
mechanism by which excessive complement activation causes diseases. We previously …

Viral-derived complement inhibitors: current status and potential role in immunomodulation

H Abou-El-Hassan, H Zaraket - Experimental Biology and …, 2017 - journals.sagepub.com
The complement system is one of the body's major innate immune defense mechanisms in
vertebrates. Its function is to detect foreign bodies and promote their elimination through …

[HTML][HTML] Delayed hemolytic transfusion reaction in a patient with sickle cell disease and the role of the classical complement pathway: a case report

PS Hair, TP Heck, DT Carr, KD Watson… - Journal of …, 2021 - ncbi.nlm.nih.gov
A 14-year-old female patient with sickle cell disease developed a severe delayed hemolytic
transfusion reaction (DHTR) leading to multiple transfusions and intensive care …